Literature DB >> 19421139

The role of PAK-1 in activation of MAP kinase cascade and oncogenic transformation by Akt.

P R Somanath1, J Vijai, J V Kichina, T Byzova, E S Kandel.   

Abstract

The activity of protein kinase B, also known as Akt, is commonly elevated in human malignancies and plays a crucial role in oncogenic transformation. The relationship between Akt and the mitogen-activated protein kinase cascade, which is also frequently associated with oncogenesis, remains controversial. We report here examples of cooperation between Akt and cRaf in oncogenic transformation, which was accompanied by elevated activity of extracellular signal-regulated mitogen-activated protein kinases. The effect of Akt on extracellular signal-regulated kinases depended on the status of p21-activated kinase (PAK). Importantly, disruption of the function of PAK not only uncoupled the activation of Akt from that of extracellular signal-regulated kinases, but also greatly reduced the capacity of Akt to act as a transforming oncogene. For the malignancies with hyperactive Akt, our observations support the role for PAK-1 as a potential target for therapeutic intervention.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19421139      PMCID: PMC2982142          DOI: 10.1038/onc.2009.114

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  27 in total

1.  Akt/Protein kinase B inhibits cell death by preventing the release of cytochrome c from mitochondria.

Authors:  S G Kennedy; E S Kandel; T K Cross; N Hay
Journal:  Mol Cell Biol       Date:  1999-08       Impact factor: 4.272

2.  Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line.

Authors:  J P Morgenstern; H Land
Journal:  Nucleic Acids Res       Date:  1990-06-25       Impact factor: 16.971

3.  Oncogenic Neu/ErbB-2 increases ets, AP-1, and NF-kappaB-dependent gene expression, and inhibiting ets activation blocks Neu-mediated cellular transformation.

Authors:  C K Galang; J García-Ramírez; P A Solski; J K Westwick; C J Der; N N Neznanov; R G Oshima; C A Hauser
Journal:  J Biol Chem       Date:  1996-04-05       Impact factor: 5.157

4.  Activation of Raf as a result of recruitment to the plasma membrane.

Authors:  D Stokoe; S G Macdonald; K Cadwallader; M Symons; J F Hancock
Journal:  Science       Date:  1994-06-03       Impact factor: 47.728

5.  Kinase-deficient Pak1 mutants inhibit Ras transformation of Rat-1 fibroblasts.

Authors:  Y Tang; Z Chen; D Ambrose; J Liu; J B Gibbs; J Chernoff; J Field
Journal:  Mol Cell Biol       Date:  1997-08       Impact factor: 4.272

6.  Cooperative regulation of the cell division cycle by the protein kinases RAF and AKT.

Authors:  Amer M Mirza; Stephan Gysin; Nisar Malek; Kei-ichi Nakayama; James M Roberts; Martin McMahon
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

7.  The protein kinase Pak3 positively regulates Raf-1 activity through phosphorylation of serine 338.

Authors:  A J King; H Sun; B Diaz; D Barnard; W Miao; S Bagrodia; M S Marshall
Journal:  Nature       Date:  1998-11-12       Impact factor: 49.962

Review 8.  RNA interference in cancer.

Authors:  Andrei L Gartel; Eugene S Kandel
Journal:  Biomol Eng       Date:  2006-02-08

9.  Tumor measurement in the nude mouse.

Authors:  D M Euhus; C Hudd; M C LaRegina; F E Johnson
Journal:  J Surg Oncol       Date:  1986-04       Impact factor: 3.454

10.  Dependence of energy metabolism on the density of cells in culture.

Authors:  J Bereiter-Hahn; A Münnich; P Woiteneck
Journal:  Cell Struct Funct       Date:  1998-04       Impact factor: 2.212

View more
  32 in total

Review 1.  PAK1 as a therapeutic target.

Authors:  Julia V Kichina; Anna Goc; Belal Al-Husein; Payaningal R Somanath; Eugene S Kandel
Journal:  Expert Opin Ther Targets       Date:  2010-07       Impact factor: 6.902

2.  p70 S6-kinase mediates the cooperation between Akt1 and Mek1 pathways in fibroblast-mediated extracellular matrix remodeling.

Authors:  Anna Goc; Harika Sabbineni; Maha Abdalla; Payaningal R Somanath
Journal:  Biochim Biophys Acta       Date:  2015-04-02

3.  P21-activated kinase 1 regulates resistance to BRAF inhibition in human cancer cells.

Authors:  Mahamat Babagana; Sydney Johnson; Hannah Slabodkin; Wiam Bshara; Carl Morrison; Eugene S Kandel
Journal:  Mol Carcinog       Date:  2017-02-23       Impact factor: 4.784

Review 4.  Novel roles of Src in cancer cell epithelial-to-mesenchymal transition, vascular permeability, microinvasion and metastasis.

Authors:  Ami Patel; Harika Sabbineni; Andrea Clarke; Payaningal R Somanath
Journal:  Life Sci       Date:  2016-05-28       Impact factor: 5.037

5.  Group I p21-activated kinases regulate thyroid cancer cell migration and are overexpressed and activated in thyroid cancer invasion.

Authors:  Samantha K McCarty; Motoyasu Saji; Xiaoli Zhang; David Jarjoura; Alfredo Fusco; Vasyl V Vasko; Matthew D Ringel
Journal:  Endocr Relat Cancer       Date:  2010-10-29       Impact factor: 5.678

6.  The role of polo-like kinase 3 in the response of BRAF-mutant cells to targeted anticancer therapies.

Authors:  Mahamat Babagana; Julia V Kichina; Hannah Slabodkin; Sydney Johnson; Alexei Maslov; Lorin Brown; Kristopher Attwood; Mikhail A Nikiforov; Eugene S Kandel
Journal:  Mol Carcinog       Date:  2019-09-30       Impact factor: 4.784

7.  Combinatorial treatments that overcome PDGFRβ-driven resistance of melanoma cells to V600EB-RAF inhibition.

Authors:  Hubing Shi; Xiangju Kong; Antoni Ribas; Roger S Lo
Journal:  Cancer Res       Date:  2011-08-01       Impact factor: 12.701

8.  PAK1 inhibitor IPA-3 mitigates metastatic prostate cancer-induced bone remodeling.

Authors:  Arti Verma; Sandeep Artham; Abdulrahman Alwhaibi; Mir S Adil; Brian S Cummings; Payaningal R Somanath
Journal:  Biochem Pharmacol       Date:  2020-03-30       Impact factor: 5.858

9.  P21 activated kinase-1 (Pak1) promotes prostate tumor growth and microinvasion via inhibition of transforming growth factor β expression and enhanced matrix metalloproteinase 9 secretion.

Authors:  Anna Goc; Ahmad Al-Azayzih; Maha Abdalla; Belal Al-Husein; Sravankumar Kavuri; Jeffrey Lee; Kelvin Moses; Payaningal R Somanath
Journal:  J Biol Chem       Date:  2012-12-20       Impact factor: 5.157

10.  AKT upregulates B-Raf Ser445 phosphorylation and ERK1/2 activation in prostate cancer cells in response to androgen depletion.

Authors:  Seung-Keun Hong; Joseph H Jeong; Andrew M Chan; Jong-In Park
Journal:  Exp Cell Res       Date:  2013-05-20       Impact factor: 3.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.